Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pulmonary HypertensionPulmonary Arterial Hypertension
Interventions
DIAGNOSTIC_TEST

Right heart catheterization

RHC is commonly used essential test to make gold-standard diagnosis of PH with mPAP \>20 mmHg. All multimodal data from patients eligible for inclusion would be randomly assigned to development datasets (70% of the study population) to train the artificial intelligence models for the detection of PH, which would be validated and tested by other datasets (30% of the study population).

Trial Locations (1)

100037

RECRUITING

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Chinese Pulmonary Vascular Disease Research Group

OTHER